Vice-president of research and development (R&D) Dr.
Trevor Calkins discusses Pfanstiehl’s active pharmaceutical ingredients (API) contract development and manufacturing organisation (CDMO) philosophy and capabilities at the CPhI/InformEx exhibition in Philadelphia.
Pfanstiehl offers a wide array of API development services at its campus just north of Chicago.
The company has one of the first Safebridge-certified facilities in the world and is passionate about solving complex chemistry challenges.
The company is focused on being in lockstep with clients from early preclinical through commercialisation.
Pfanstiehl
![](https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/icons/success.png)
Subscribed
You have successfully submitted your enquiry. Someone from our company will respond ASAP